Literature DB >> 15366427

Sudden, unexpected death in cardiac transplant recipients: an autopsy study.

Chavit Chantranuwat1, John D Blakey, Jon A Kobashigawa, Jaime D Moriguchi, Hillel Laks, Maria Espejo Vassilakis, Michael C Fishbein.   

Abstract

BACKGROUND: Clinical studies indicate that sudden death (SD) is common after heart transplantation. Autopsy reports of such patients are sparse.
METHODS: We performed a retrospective study of clinical and pathologic findings on all autopsied patients who underwent heart transplantation at our institution from January 1984 to July 2002.
RESULTS: There were 74 patients who survived >2 months. Of these, 28 (37.8%) died suddenly. The major causes of sudden death (SD) included acute cellular rejection (ACR) (n = 11, 39.3%) and graft coronary artery disease (GCAD) (n = 11, 39.3%). In 9 patients (32.1%), there was no anatomic cause of death. These deaths, assumed to be primary arrhythmic death (PAD), occurred 5 to 36 months post-transplantation. Pre-transplant diagnosis of idiopathic dilated cardiomyopathy (IDCM) was more common in SD (13 of 28, 46.4% vs 9 of 46, 19.6%; p = 0.014). Hypertrophy was not statistically different in SD vs non-SD (79.4% vs 88.4%; p = 0.38). Coronary thrombosis was also not statistically different in sudden GCAD deaths vs non-sudden GCAD deaths (3 of 11, 27.3% vs 8 of 13, 61.5%; p = 0.09). ACR SD patients had fewer episodes of ACR in biopsies than ACR non-SD patients (93 of 190, 48.9% vs 99 of 159, 63.3%; p = 0.01). Biopsies with Quilty lesions (QL) were more frequent in patients with SD (206 of 461, 44.7% vs 243 of 710, 34.2%; p < 0.001). QL were more common in patients with GCAD (44.4%) and ACR (39.6%) than in patients who died of infection (25.7%; P < 0.001 and p < 0.01, respectively).
CONCLUSIONS: SD after cardiac transplantation is common (37.8% of all deaths). ACR, in the first year, and GCAD, afterwards, are associated with SD. PAD occurred in 32.1% of SD cases, 5 to 36 months after transplantation. Pre-transplant diagnoses of IDCM and QL are more common in SD. Surprisingly, cardiac hypertrophy is not increased and coronary thrombosis is not more frequent in patients who died suddenly.

Entities:  

Mesh:

Year:  2004        PMID: 15366427     DOI: 10.1016/s1053-2498(03)00295-x

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  6 in total

Review 1.  Impact of hyperlipidemia on alloimmunity.

Authors:  Jessamyn Bagley; Jin Yuan; John Iacomini
Journal:  Curr Opin Organ Transplant       Date:  2017-02       Impact factor: 2.640

2.  International Society of Heart and Lung Transplantation position statement on the role of right heart catheterization in the management of heart transplant recipients.

Authors:  Hoong Sern Lim; Eileen Hsich; Keyur B Shah
Journal:  J Heart Lung Transplant       Date:  2018-12-21       Impact factor: 10.247

3.  Sudden death after pediatric heart transplantation: analysis of data from the Pediatric Heart Transplant Study Group.

Authors:  Kevin P Daly; Sujata B Chakravarti; Margaret Tresler; David C Naftel; Elizabeth D Blume; Anne I Dipchand; Christopher S Almond
Journal:  J Heart Lung Transplant       Date:  2011-10-13       Impact factor: 10.247

4.  Case Report: Family Curse: An SCN5A Mutation, c.611C>A, p.A204E Associated With a Family History of Dilated Cardiomyopathy and Arrhythmia.

Authors:  Wen Huang; Rui Xu; Ning Gao; Xia Wu; Cong Wen
Journal:  Front Cardiovasc Med       Date:  2022-05-06

5.  Mode and mechanisms of death after orthotopic heart transplantation.

Authors:  Marmar Vaseghi; Nicolas Lellouche; Harry Ritter; Gregg C Fonarow; Jignesh K Patel; Jaime Moriguchi; Michael C Fishbein; Jon A Kobashigawa; Kalyanam Shivkumar
Journal:  Heart Rhythm       Date:  2009-01-16       Impact factor: 6.343

6.  Arrhythmias after heart transplantation: mechanisms and management.

Authors:  Anees Thajudeen; Eric C Stecker; Michael Shehata; Jignesh Patel; Xunzhang Wang; John H McAnulty; Jon Kobashigawa; Sumeet S Chugh
Journal:  J Am Heart Assoc       Date:  2012-04-24       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.